Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Sales | 0 | 0 | 8 | 0 | 0 |
| Gross Profit | N/A | N/A | 8 | N/A | N/A |
| Operating Expenses | 38,262 | 30,560 | 6,331 | 0 | 0 |
| Operating Income | -38,262 | -30,560 | -6,323 | N/A | N/A |
| Interest Expense | 1,491 | 185 | 100 | 0 | 0 |
| Other Income | 0 | -9,743 | 189 | 0 | 0 |
| Pre-tax Income | -39,753 | -40,488 | -6,234 | 0 | 0 |
| Income Tax | 7 | -153 | 153 | N/A | N/A |
| Net Income Continuous | -39,760 | -40,335 | -6,387 | N/A | N/A |
| Net Income | $-39,760 | $-40,335 | $-6,387 | $N/A | $N/A |
| EPS Basic Total Ops | -1.69 | -3.11 | -0.79 | N/A | N/A |
| EPS Basic Continuous Ops | -1.69 | -3.11 | -0.64 | N/A | N/A |
| EPS Diluted Total Ops | -1.69 | -3.11 | -0.79 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.69 | -3.11 | -0.64 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.69 | -3.11 | N/A | N/A | N/A |
| EBITDA(a) | $-35,533 | $-28,941 | $-6,248 | $N/A | $N/A |